Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Aspartate carbamoyltransferase catalytic subunit is the enzyme responsible for the condensation of carbamoyl phosphate and aspartate to form carbamoyl aspartate and inorganic phosphate, a committed and rate-limiting step in the de novo biosynthesis of pyrimidine nucleotides (UMP, CTP)[2][6][8]. In organisms such as Escherichia coli, the enzyme consists of a large multimeric complex with six catalytic subunits (arranged as two trimers) at its core and three regulatory dimers, for a total molecular weight over 300 kDa[2][5]. The catalytic subunits perform the enzymatic reaction; the regulatory subunits control enzyme activity through allosteric interactions, modulating the enzyme’s state between inactive (“T” or tense) and active (“R” or relaxed) conformations depending on the levels of purine and pyrimidine nucleotides, thus tightly regulating nucleotide synthesis[2][5]. Key allosteric inhibitors include CTP (end product of the pathway), and activators include ATP[2][5]. The bacterial gene encoding the catalytic subunit is called pyrB[6]. Aspartate carbamoyltransferase does not have a direct clinical role in humans but serves as a model for understanding enzyme allostery, regulation, and is of microbial biochemical importance. Inhibitors like PALA are used as biochemical tools for mechanistic and structural studies[1][5].
Competitive inhibition (e.g., by PALA which mimics the transition state) Allosteric regulation (CTP as negative effector, ATP as positive effector regulates activity through the regulatory subunit, but not directly acting as inhibitor of the catalytic subunit itself)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aspartate carbamoyltransferase catalytic subunit (ATCase (catalytic subunit)).